Soft Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

All the vital news, analysis, and commentary curated by our industry experts.

$4000

Buy Report View Sample

Published: August 21, 2023 Report Code: GDME1601EPD-ST

Report Overview
Key Players
Table of Contents
Table
Figures

Soft contact lenses are corrective gel-like lenses that conform to the shape of the eye. GlobalData’s Medical Devices sector report, “Soft Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” provides comprehensive information about the Soft Contact Lenses pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Soft Contact Lenses report provides key information and data related to:
Extensive coverage of the Soft Contact Lenses under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Soft Contact Lenses pipeline products.
Review of Recent Developments in the segment / industry
The Soft Contact Lenses report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Soft Contact Lenses under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Soft Contact Lenses under development _x000D_

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities_x000D_

– The report reviews the major players involved in the development of Soft Contact Lenses and list all their pipeline projects_x000D_

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage_x000D_

– The report provides key clinical trial data of ongoing trials specific to pipeline products_x000D_

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to – _x000D_

– Formulate significant competitor information, analysis, and insights to improve R&D strategies_x000D_

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage_x000D_

– Identify and understand important and diverse types of Soft Contact Lenses under development_x000D_

– Develop market-entry and market expansion strategies_x000D_

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline_x000D_

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Alcon Inc
Alcon Laboratories Inc
Bausch & Lomb Inc
BVS Sight Inc
Clerio Vision Inc
Fitlens Ltd
Imperial College London
Industrial Science & Technology Network Inc
Innovega Inc
Johnson & Johnson Vision Care Inc
Lentechs LLC
Lipocoat BV
Ocutec Ltd
Purdue University
Queen's University
Smartlens Inc
Visioneering Technologies Inc
VISTAKON Pharmaceuticals LLC

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Soft Contact Lenses Overview 8

3 Products under Development 9

3.1 Soft Contact Lenses – Pipeline Products by Stage of Development 9

3.2 Soft Contact Lenses – Pipeline Products by Territory 10

3.3 Soft Contact Lenses – Pipeline Products by Regulatory Path 11

3.4 Soft Contact Lenses – Pipeline Products by Estimated Approval Date 12

3.5 Soft Contact Lenses – Ongoing Clinical Trials 13

4 Soft Contact Lenses – Pipeline Products under Development by Companies 14

4.1 Soft Contact Lenses Companies – Pipeline Products by Stage of Development 14

4.2 Soft Contact Lenses – Pipeline Products by Stage of Development 15

5 Soft Contact Lenses Companies and Product Overview 16

5.1 Alcon Inc Company Overview 16

5.1.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Alcon Laboratories Inc Company Overview 20

5.2.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Bausch & Lomb Inc Company Overview 24

5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 BVS Sight Inc Company Overview 26

5.4.1 BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Clerio Vision Inc Company Overview 27

5.5.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Fitlens Ltd Company Overview 28

5.6.1 Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Imperial College London Company Overview 31

5.7.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 Industrial Science & Technology Network Inc Company Overview 32

5.8.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Innovega Inc Company Overview 33

5.9.1 Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Johnson & Johnson Vision Care Inc Company Overview 34

5.10.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Lentechs LLC Company Overview 35

5.11.1 Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Lipocoat BV Company Overview 38

5.12.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 Ocutec Ltd Company Overview 39

5.13.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Purdue University Company Overview 40

5.14.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 40

5.15 Queen’s University Company Overview 41

5.15.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 Smartlens Inc Company Overview 42

5.16.1 Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Visioneering Technologies Inc Company Overview 43

5.17.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 VISTAKON Pharmaceuticals LLC Company Overview 50

5.18.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 50

6 Soft Contact Lenses- Recent Developments 51

6.1 May 15, 2023: Menicon Co. Notice of Agenda Items for the 66th Annual General Meeting of Shareholders 51

6.2 Apr 20, 2023: EssilorLuxottica reports Q1 2023 revenue 51

6.3 Feb 27, 2023: Menicon Notice Regarding Change in Representative Executive Officers and Personnel Changes in Executive Officers 51

6.4 Feb 23, 2023: EssilorLuxotticaFY 2022 Results Year of records in sales, operating and net profit 52

6.5 Feb 01, 2023: Novartis Announces Annual Report 2022 53

6.6 Feb 01, 2023: Newly launched multifocal colored contact lens 2WEEK Menicon Rei multifocal realizes natural vision from near to distance 54

6.7 Jan 30, 2023: Yael Kusch Appointed Global Public Relations Manager Of Essilorluxottica 55

6.8 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22 55

6.9 Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring 56

6.10 Oct 13, 2022: Novartis to cut its Irish workforce by up to 25% 56

6.11 Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2 56

6.12 Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting 56

6.13 Sep 01, 2022: Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis 58

6.14 Aug 23, 2022: Novartis set to eliminate many leadership positions as part of 1,400 layoffs in Switzerland 58

7 Appendix 59

7.1 Methodology 59

7.2 About GlobalData 62

7.3 Contact Us 62

7.4 Disclaimer 62

Table

Soft Contact Lenses – Pipeline Products by Stage of Development 9

Soft Contact Lenses – Pipeline Products by Territory 10

Soft Contact Lenses – Pipeline Products by Regulatory Path 11

Soft Contact Lenses – Pipeline Products by Estimated Approval Date 12

Soft Contact Lenses – Ongoing Clinical Trials 13

Soft Contact Lenses Companies – Pipeline Products by Stage of Development 14

Soft Contact Lenses – Pipeline Products by Stage of Development 15

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Air Optix Plus HydraGlyde Toric Reusable Lens – Product Status 16

Air Optix Plus HydraGlyde Toric Reusable Lens – Product Description 17

Dailies Total 1 Colors SiHy Lens – Product Status 17

Dailies Total 1 Colors SiHy Lens – Product Description 17

Dailies Total 1 Precision 1 Toric SiHy Lens – Product Status 18

Dailies Total 1 Precision 1 Toric SiHy Lens – Product Description 18

Weekly WG SiHy Lens – Product Status 18

Weekly WG SiHy Lens – Product Description 19

Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Total30 Asphere – Product Status 20

Total30 Asphere – Product Description 20

Total30 For Astigmatism – Product Status 21

Total30 For Astigmatism – Product Description 21

Total30 Multifocal – Product Status 21

Total30 Multifocal – Product Description 22

Total30 Multifocal Toric – Product Status 22

Total30 Multifocal Toric – Product Description 22

TOTAL30 Soft Contact Lenses – Product Status 23

TOTAL30 Soft Contact Lenses – Product Description 23

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Aqualox SiHy Daily Lens – Product Status 24

Aqualox SiHy Daily Lens – Product Description 24

Custom Soft Contact Lens – Product Status 25

Custom Soft Contact Lens – Product Description 25

BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Smart Contact Lens – Product Status 26

Smart Contact Lens – Product Description 26

Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Bifocal Contact Lens – Product Status 27

Bifocal Contact Lens – Product Description 27

Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Myolens – Product Status 28

Myolens – Product Description 28

Fitlens Ltd – Ongoing Clinical Trials Overview 29

Myolens – An Open Label, 3 Arms, Multicenter, Randomized. To Evaluate the Effectiveness Fitlens Soft Central Near and Central Far Contact Lens, Compared With MiSight for the Control of Progressive Juvenile Onset Myopia in Children Ages 8-12 30

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 31

Contact Lens – Product Status 31

Contact Lens – Product Description 31

Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Silicone Hydrogel Contact Lens – Product Status 32

Silicone Hydrogel Contact Lens – Product Description 32

Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview 33

iOptik Contact Lens – Product Status 33

iOptik Contact Lens – Product Description 33

Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Next Generation 1-DAY ACUVUE DEFINE Contact Lens – Product Status 34

Next Generation 1-DAY ACUVUE DEFINE Contact Lens – Product Description 34

Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Apioc – Astigmatism – Product Status 35

Apioc – Astigmatism – Product Description 35

Apioc – Presbyopia – Product Status 36

Apioc – Presbyopia – Product Description 36

Apioc – Presbyopia With Astigmatism – Product Status 36

Apioc – Presbyopia With Astigmatism – Product Description 37

Apioc Sphere – Astigmatism – Product Status 37

Apioc Sphere – Astigmatism – Product Description 37

Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview 38

Lipocoat-Enabled Contact Lens – Product Status 38

Lipocoat-Enabled Contact Lens – Product Description 38

Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Third PEG Hydrogel Contact Lens – Product Status 39

Third PEG Hydrogel Contact Lens – Product Description 39

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 40

Soft Contact Lens – Ocular Disease Monitoring – Product Status 40

Soft Contact Lens – Ocular Disease Monitoring – Product Description 40

Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 41

Non-Invasive IOP Monitoring Soft Contact Lens – Product Status 41

Non-Invasive IOP Monitoring Soft Contact Lens – Product Description 41

Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview 42

miLens – Product Status 42

miLens – Product Description 42

Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Product Status 43

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Product Description 44

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Product Status 44

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Product Description 44

NaturalVue Toric 1 Day Contact Lenses – Product Status 45

NaturalVue Toric 1 Day Contact Lenses – Product Description 45

NaturalVue Toric Multifocal 1 Day Contact Lenses – Product Status 45

NaturalVue Toric Multifocal 1 Day Contact Lenses – Product Description 46

Next Gen NaturalVue MF Contact Lens – Product Status 46

Next Gen NaturalVue MF Contact Lens – Product Description 46

Visioneering Technologies Inc – Ongoing Clinical Trials Overview 47

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial 48

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Myopia Control in the Pediatric Population: A Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05% 49

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Myopia Progression in Children and Adolescents Before and after Use of a Novel Extended Depth of Focus Daily Disposable Soft Contact Lens 49

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial 49

VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 50

K-Lens – Product Status 50

K-Lens – Product Description 50

Glossary 61

Figures

Soft Contact Lenses – Pipeline Products by Stage of Development 9

Soft Contact Lenses – Pipeline Products by Territory 10

Soft Contact Lenses – Pipeline Products by Regulatory Path 11

Soft Contact Lenses – Pipeline Products by Estimated Approval Date 12

Soft Contact Lenses – Ongoing Clinical Trials 13

Frequently asked questions

Soft Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports

Currency USD

Single User

$4,000

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Soft Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

Assess the relevance of the report
Evaluate the quality of the report
Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Soft Contact Lenses reports

Medical Devices

Germany Surgical Stapling Devices Market Size (Value, Volume, ASP) by…

Medical Devices

India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…

Medical Devices

Japan Surgical Energy Instruments Market Size (Value, Volume, ASP) by…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Soft Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

Access a live Soft Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Soft Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Scope

Reasons to Buy

Table of Contents

Table

Figures

Frequently asked questions

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Sample Report

Below is a sample report to understand what you are buying

Related reports